BENDEKA (BENDAMUSTINE HCI) INJECTION

USPTO USPTO 2015 SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark BENDEKA (BENDAMUSTINE HCI) INJECTION was filed as Word and figurative mark on 11/20/2015 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 08/02/2016. The current status of the mark is "SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED".

Logodesign (Wiener Klassifikation)

#Thread wound on a shuttle, shuttles with or without thread #Polygons containing one or more circles or ellipses (specify the content) #USPTO: 26.05.28 - Triangular shape (miscellaneous overall shape), Miscellaneous designs with overall triangular shape

Trademark Details Last update: February 19, 2023

Trademark form Word and figurative mark
File reference 5014704
Register number 86826912
Application date November 20, 2015
Entry date August 2, 2016
Expiration date August 2, 2026

Trademark owner

145 Brandywine Parkway
19380 West Chester
US

Trademark representatives

400 Interpace Parkway, Building A 07054 Parsippany US

goods and services

44 Medical, beauty and agricultural services

ID: 13